|
NOL6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.350500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.182950E-01 |
| Normal-vs-Stage2 |
2.184200E-01 |
| Normal-vs-Stage3 |
2.039400E-01 |
| Normal-vs-Stage4 |
1.217680E-02 |
| Stage1-vs-Stage2 |
7.477600E-01 |
| Stage1-vs-Stage3 |
9.575800E-01 |
| Stage1-vs-Stage4 |
5.754100E-02 |
| Stage2-vs-Stage3 |
7.455200E-01 |
| Stage2-vs-Stage4 |
3.832200E-01 |
| Stage3-vs-Stage4 |
1.149830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.747600E-02 |
| Normal-vs-AfricanAmerican |
2.680400E-01 |
| Normal-vs-Asian |
4.592100E-02 |
| Caucasian-vs-AfricanAmerican |
7.369400E-01 |
| Caucasian-vs-Asian |
7.567800E-01 |
| AfricanAmerican-vs-Asian |
5.705800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.050380E-01 |
| Normal-vs-Female |
9.155700E-02 |
| Male-vs-Female |
7.792800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.178000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.356000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.604400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.562020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.577200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.511600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.622600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.500800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.151600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.114400E-01 |
| Classical-VS-Follicular |
6.22179996412342E-09 |
| Classical-VS-Other |
6.738100E-02 |
| Classical-VS-Normal |
1.738470E-03 |
| Tall-VS-Follicular |
8.836000E-03 |
| Tall-VS-Other |
1.354560E-01 |
| Tall-VS-Normal |
1.028960E-01 |
| Follicular-VS-Other |
8.866200E-01 |
| Follicular-VS-Normal |
1.852790E-01 |
| Other-VS-Normal |
5.886800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.362000E-01 |
| Normal-vs-N1 |
6.372600E-01 |
| N0-vs-N1 |
6.248600E-01 |
|
|
